Antisense Oligonucleotide Gene Therapy for Neuromuscular Disorders

University of Ottawa Journal of Medicine
doi 10.18192/uojm.v8i2.3462
Full Text
Abstract

Available in full text

Date
Authors
Publisher

University of Ottawa Library

Related search

Antisense Gene Silencing: Therapy for Neurodegenerative Disorders?

Genes
Genetics
2013English

Antisense Oligonucleotide Therapy for Neurodegenerative Disease

Journal of Clinical Investigation
Medicine
2006English

124. AAV-Mediated Antisense Oligonucleotide-Based Therapy for CEP290-Associated LCA

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Antisense Gene Therapy for Neurodegenerative Disease?

Experimental Neurology
Developmental NeuroscienceNeurology
1997English

Antisense Oligonucleotide Hope for Childhood Epilepsies

Nature Reviews Neurology
Molecular NeuroscienceNeurologyCellular
2020English

Antisense Oligonucleotide Treatment for Human Astrocytoma

Genome Biology
2001English

SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy

JAMA Neurology
Neurology
2013English

Down-Regulation of a Gene-Expression by an Antisense BNA Oligonucleotide.

Folia Pharmacologica Japonica
Pharmacology
2002English

Oligonucleotide-Based Gene Therapy for Cardiovascular Disease Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs

Current Drug Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy